Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1342561 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL28640336 | 0.77 | — | — | |
| SCHEMBL11211880 | 0.77 | — | — | |
| SCHEMBL28860083 | 0.71 | — | — | |
| SCHEMBL163584 | 0.71 | — | — | |
| SCHEMBL28906986 | 0.69 | — | — | |
| SCHEMBL29478191 | 0.69 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL8587755 | 0.69 | — | — | |
| SCHEMBL11791161 | 0.68 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL11896621 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023230099-A1 | COMPOSITIONS COMPRISING OLIGONUCLEOTIDE AND USES THEREOF | SIRNAGEN THERAPEUTICS INCORPORATED (US) | 2023-11-30 | — | — | WO | claimed |
| US-20210189398-A1 | AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME | BIONEER CORPORATION (KR) | 2021-06-24 | — | — | US | claimed |
| US-20150259690-A1 | AMPHIREGULIN-SPECIFIC DOUBLE-HELICAL OLIGO-RNA, DOUBLE-HELICAL OLIGO-RNA STRUCTURE COMPRISING DOUBLE-HELICAL OLIGO-RNA, AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES CONTAINING SAME | BIONEER CORPORATION (KR) | 2015-09-17 | — | — | US | claimed |
| WO-2023230099-A1 | COMPOSITIONS COMPRISING OLIGONUCLEOTIDE AND USES THEREOF | SIRNAGEN THERAPEUTICS INCORPORATED (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20220118093-A1 | DOUBLE STRANDED OLIGONUCLEOTIDE CONSTRUCT COMPRISING ANDROGEN RECEPTOR SPECIFIC SEQUENCE, AND COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH COMPRISING SAME | BIONEER CORPORATION (KR) | 2022-04-21 | — | — | US | disclosed |
| US-20210299225-A1 | COMPOSITION FOR TREATING OR SENSITIZING INTERFERON BETA RESISTANT CANCER DISEASE COMPRISING CFLIP SIRNA | ABION INC. (KR) | 2021-09-30 | — | — | US | disclosed |
| US-9695421-B2 | Dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and composition for suppressing proliferation of dengue virus comprising RNA structure | BIONEER CORPORATION (KR) | 2017-07-04 | — | — | US | disclosed |
| US-20170152512-A1 | IMPROVED NANOPARTICLE TYPE OLIGONUCLEOTIDE STRUCTURE HAVING HIGH EFFICIENCY AND METHOD FOR PREPARING SAME | BIONEER CORPORATION (KR) | 2017-06-01 | — | — | US | disclosed |
| US-20150259690-A1 | AMPHIREGULIN-SPECIFIC DOUBLE-HELICAL OLIGO-RNA, DOUBLE-HELICAL OLIGO-RNA STRUCTURE COMPRISING DOUBLE-HELICAL OLIGO-RNA, AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES CONTAINING SAME | BIONEER CORPORATION (KR) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259690-A1 | AMPHIREGULIN-SPECIFIC DOUBLE-HELICAL OLIGO-RNA, DOUBLE-HELICAL OLIGO-RNA STRUCTURE COMPRISING DOUBLE-HELICAL OLIGO-RNA, AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES CONTAINING SAME | AREG, OGFRL1, IGF2BP2 | ALDH1A1 4711/4885 |
| US-20170152512-A1 | IMPROVED NANOPARTICLE TYPE OLIGONUCLEOTIDE STRUCTURE HAVING HIGH EFFICIENCY AND METHOD FOR PREPARING SAME | PHAX, RPRD2, SMC2 | ALDH1A1 4534/4885 |
| US-20210189398-A1 | AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME | AREG, HDGF, MSTN | ALDH1A1 4337/4885 |
| US-20220118093-A1 | DOUBLE STRANDED OLIGONUCLEOTIDE CONSTRUCT COMPRISING ANDROGEN RECEPTOR SPECIFIC SEQUENCE, AND COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH COMPRISING SAME | AR, SHBG, NR5A1 | ALDH1A1 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.